We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
You must tell DVLA if you have obstructive sleep apnoea syndrome (OSAS) or any sleep condition or apnoea which causes excessive sleepiness.
The CMA investigated alleged excessive and unfair pricing, anti-competitive agreements and abusive conduct with respect to hydrocortisone tablets under Chapters I and II CA98 and Articles 101 and 102 TFEU.
Alert to the possible problems caused by excessive harmonic distortion of electrical systems onboard vessels.
Advice for medical professionals to follow when assessing drivers with miscellaneous conditions.
Tougher sentences for cowardly killers delivered a year on from Wade Review.
How to make sure your business’ terms and conditions are fair, and avoid unfair contract terms
Find out what unacceptable or unreasonable actions are and how we approach them.
An analysis of people who were killed and seriously injured due to excessive speed and identifying any emerging trends which could be used by departmental officials to reduce casualty numbers.
The CMA investigated alleged excessive and unfair pricing with respect to liothyronine tablets under Chapter II CA98.
The CAT has unanimously upheld the level of penalty imposed by the CMA for a market sharing agreement relating to 20mg hydrocortisone tablets.
Firms which raised prices for key medicine by over 10,000% from 70p to £72 have had their appeal against a CMA finding of excessive pricing rejected by the Competition Appeal Tribunal (CAT). The firms must now pay almost £130m in...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.